![Gustav Gaudernack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gustav Gaudernack
Geen lopende functies
Health Technology
Profiel
Gustav Gaudernack is the founder of Circio Holding ASA, which was founded in 2010.
Currently, he is the Chief Scientific Officer at Ultimovacs ASA. Previously, he worked as a Professor at Norwegian Radium Hospital from 1995 to 2011.
Eerdere bekende functies van Gustav Gaudernack
| Bedrijven | Functie | Einde |
|---|---|---|
Norwegian Radium Hospital | Corporate Officer/Principal | 01-01-2011 |
Ultimovacs ASA
 Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Hoofd Techniek/Wetenschap/O&O | - |
| CIRCIO HOLDING ASA | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Norwegian Radium Hospital |
